Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement
A new $7.4 billion opioid settlement for Purdue Pharma and the Sackler family has been approved by all U.S. states and territories
OxyContin
It's money v. principle in Supreme Court opioid case
The justices struggled to decide whether to give a thumbs up or thumbs down to the multi-billion dollar Purdue Pharma bankruptcy deal--a deal meant to compensate victims of OxyContin.
Purdue Pharma, Sacklers' OxyContin settlement lands at the Supreme Court
Under the deal, Purdue agreed it owed $8 billion in criminal and civil fines. That deal is at the center of Monday's case because it releases the Sacklers from personal liability.
Sackler family is willing to pay more in Purdue opioids settlement, mediator says
Under the latest proposal, the Sacklers would contribute between $5.5 billion and $6 billion, an increase from the $4.3 billion they had agreed to earlier.
The DOJ Moves To Block The Purdue Pharma Bankruptcy Deal That Shields The Sacklers
The DOJ is seeking to block implementation of any part of the Purdue Pharma bankruptcy deal until legal challenges are settled. The deal granted Sackler family members immunity from opioid lawsuits.
As Purdue Pharma Bankruptcy Nears Approval, Family Members Write About The Human Toll
The Purdue Pharma bankruptcy process has focused on financial compensation to creditors, but court records include heartrending personal letters from families ravaged by Oxycontin.
Justice Department Blasts Purdue Pharma's Bankruptcy Plan
Two divisions of the DOJ argue the deal improperly shelters members of the Sackler family and their associates from liability. States are finalizing a separate deal with other opioid companies.
15 States Drop Opposition To Controversial Purdue Pharma OxyContin Bankruptcy
Massachusetts and New York are among the states agreeing to end the fight to halt a controversial Purdue Pharma bankruptcy plan. The deal shelters members of the Sackler family from opioid lawsuits.
Judge Blocks Lawsuits Against Sackler Family As Oxycontin Bankruptcy Talks Continue
Two dozen states had hoped to sue the owners of Purdue Pharma for their alleged role in the opioid crisis. But a federal bankruptcy has judge put the brakes on — again — until April 21.
Purdue Pharma Offers Restructuring Plan, Sackler Family Would Give Up Ownership
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.